Jiangxi Fushine Pharmaceutical Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is PIPERACILLIN, with a corresponding US DMF Number 32483.
Remarkably, this DMF maintains an Active status since its submission on January 29, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 03, 2019, and payment made on May 09, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II